Federal Circuit Hits J&J Unit With One-Two Punch
In a blow to Johnson & Johnson, the U.S. Court of Appeals for the Federal Circuit has sided with Mylan Laboratories Inc. in the brawl over blockbuster incontinence drug Ditropan XL,...To view the full article, register now.
Already a subscriber? Click here to view full article